mutations given The reality that, as explained beneath, CLL therapy is based over the existence or absence of those mutations. The current consensus is, besides clonal mutations, subclonal mutations by using a variant allelic frequency starting from five to 10% (and therefore beneath the edge of detection by regular molecular approaches) may be doc